1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
679E1C736B81029D900258BA30029C1D6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-more-effective-medical-affairs-product-launch-teams-oncology-segment
18
19
2044.192.95.161
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Oncology Segment

ID: POP-391


Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives


Pages: 56


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Oncology is the most competitive and rapidly advancing therapeutic area in healthcare, where Medical Affairs teams play a pivotal role in ensuring that new treatments reach patients effectively. Medical's involvement is critical in navigating the complexities of cancer treatment and aligning with evolving clinical and regulatory standards.

Best Practices, LLC conducted this research to explore the role of Medical Affairs in successful oncology product launches. This report examines Medical Affairs' evolving responsibilities, cross-functional collaboration, evidence dissemination, resourcing, and the strategic use of digital tools. Our research also identifies the critical success factors and challenges that are unique to oncology, ensuring Medical Affairs teams are positioned to launch effectively and drive impact.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Chemical; Consulting; Communications; Consumer Products; Medical Device; Science


Companies Profiled:
AstraZeneca; Boehringer Ingelheim; Eisai; EMD Serono; Eurofarma; Genentech; GRAIL; Helsinn; Ipsen; Karyopharm Therapeutics; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pfizer; Pixacore; Sandoz; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Thermo Fisher Scientific

Study Snapshot

Best Practices, LLC engaged 27 Medical leaders from 20 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

  • Medical Leadership Roles and Launch Activity Effectiveness in Oncology
  • Ensuring Cross-functional Alignment and Collaboration in Oncology Launches
  • Medical Launch Evolution in Oncology Segment
  • Oncology Launch Activities Timeline, Performance Tracking, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During Oncology Launches
  • Digital Launch Implementation and Impact in Oncology
  • Launch Tool Deployment for Oncology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Launch Activity Effectiveness: In the oncology segment, Medical Affairs plays a critical role in product launches, particularly in education and support functions. Educational activities are led by 86% of teams, with 78% rating them as effective. Organizational support is led by 53%, with 72% finding it effective. In contrast, Communication and Data Dissemination activities see less leadership (30%), with 67% rating them effective. Research is led by 52%, with 71% finding it effective. These insights highlight the need for stronger leadership in communication efforts to optimize launch success in oncology.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4
II.
Section I: Launch Excellence and Medical’s Role & Activity EffectivenessPg. 6-12
III.
Section II: Ensuring Cross-functional Alignment and CollaborationPg. 13-15
IV.
Section III: Adopting to Ongoing Changes in Medical LandscapePg. 16-20
V.
Section IV: Launch Timeline, Preparedness Metrics, and ResourcingPg. 21-26
VI.
Section V: Critical Success Factors and Major PitfallsPg. 27-32
VII.
Section VI: Digital Influence on Launch Processes and Launch Tool DeploymentPg. 33-41
VIII.
Section VII: Participant DemographicsPg. 42-43
IX.
Section VIII: Detailed Benchmark Study DataPg. 44-55
X.
Section IX: About Best Practices, LLCPg. 56

    List of Charts & Exhibits

    I. Launch Excellence and Medical’s Role & Activity Effectiveness

    • Medical launch excellence framework
    • Medical Affairs’ role in oncology launches
    • Medical leadership roles in oncology launches
    • Medical Affairs’ effectiveness in oncology launch activities
    • Most effective launch activities for Medical Affairs in oncology
    • Improvement opportunities for Medical Affairs around oncology launch activities
    II. Ensuring Cross-functional Alignment and Collaboration

    • Medical Affairs’ work with internal colleagues to ensure successful oncology launches
    • Role of Medical Affairs group in cross-functional oncology launch teams

    III. Adopting to Ongoing Changes in Medical Landscape

    • Change fronts for Medical launch evolution
    • Medical Affairs’ launch evolution around digital data dissemination and communication
    • Medical Affairs’ launch evolution around medical education
    • Medical Affairs’ launch evolution around organizational support

    IV. Launch Timeline, Preparedness Metrics and Resourcing

    • Medical Affairs’ oncology launch activities timeline
    • Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for oncology products during each of the years in launch phase
    • Launch dashboard and information used with the dashboard for oncology
    • Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in oncology
    • Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in oncology

    V. Critical Success Factors and Major Pitfalls

    • Critical success factors for Medical Affairs in oncology launches
    • Areas where advanced team planning is key for oncology launches
    • Six critical areas for successful Medical Affairs launch readiness in oncology
    • Major pitfalls for Medical Affairs during oncology launches
    • Six major challenge areas for Medical Affairs during oncology launches

    VI. Digital Influence on Launch Processes and Launch Tool Deployment

    • Post-pandemic digital technology utilization in Medical Affairs during oncology product launches
    • Impact of digital technologies on current and future oncology launch processes
    • Digital launch tool deployment and impact
    • Impact of top three digital activities that Medical leads in oncology
    • Impact of digital activities and programs used to support a successful oncology product launch
    • Top digital tools that can bring success to Medical Affairs product launch activities
    • Fast-growing digital tools that are impacting Medicals’ launch strategy
    • Example of a valuable digital tool that supports launch activities

    VII. Participant Demographics

    • Geographic responsibility of benchmark partners

    VIII. Detailed Benchmark Study Data

    • Role served by Medical Affairs in oncology product launches
    • Medical Affairs’ launch role effectiveness in oncology
    • Role served by Medical Affairs in planning, research, and education activities in oncology segment
    • Role served by Medical Affairs in data dissemination and organizational support activities in oncology segment
    • Role served by Medical Affairs in research activities in oncology segment
    • Role served by Medical Affairs in education and data dissemination support activities in oncology segment
    • Role served by Medical Affairs in organizational support activities in oncology segment
    • Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in oncology
    • Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in oncology
    • Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in oncology
    • Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in oncology